ITGAL and systemic lupus erythematosus: Previous studies have confirmed that H3K27me3 enrichment at the CD11a promoter of SLE CD4+ T cells is distinctly decreased compared with that of healthy controls and the genomic expression of JMJD3 in CD4+ T cells is elevated in SLE patients.